Latest Euclidean Capital LLC Stock Portfolio
$795Million– No. of Holdings #11
Euclidean Capital LLC Performance:
2024 Q2: 2.06%YTD: 6.95%2023: -11.55%
Performance for 2024 Q2 is 2.06%, and YTD is 6.95%, and 2023 is -11.55%.
About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $795.8 Millions as of 30 Jun, 2024.
The top stock holdings of Euclidean Capital LLC are SPY, AMPS, FHTX. The fund has invested 78.4% of it's portfolio in SPDR S&P 500 ETF TR and 17% of portfolio in ISHARES TR.
The fund managers got completely rid off SPDR GOLD TR (GLD) and NGM BIOPHARMACEUTICALS INC (NGM) stocks. The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY).
The top stock holdings of Euclidean Capital LLC are SPY, AMPS, FHTX. The fund has invested 78.4% of it's portfolio in SPDR S&P 500 ETF TR and 17% of portfolio in ISHARES TR.
The fund managers got completely rid off SPDR GOLD TR (GLD) and NGM BIOPHARMACEUTICALS INC (NGM) stocks. The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY).
Euclidean Capital LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Euclidean Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Euclidean Capital LLC made a return of 2.06% in the last quarter. In trailing 12 months, it's portfolio return was 6.33%.
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| spdr s&p 500 etf tr | 17.68 |
Additions to existing portfolio by Euclidean Capital LLC
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| ngm biopharmaceuticals inc | -1,577,550 |
| spdr gold tr | -88,926,800 |
Euclidean Capital LLC got rid off the above stocks
Sector Distribution
Euclidean Capital LLC has about 78.4% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 78.4 |
| Utilities | 17 |
| Healthcare | 4.6 |
Market Cap. Distribution
Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 78.4 |
| SMALL-CAP | 18.6 |
| MICRO-CAP | 2.8 |
Stocks belong to which Index?
About 21.4% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 78.6 |
| RUSSELL 2000 | 21.4 |
Euclidean Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Euclidean Capital LLC
Euclidean Capital LLC has 11 stocks in it's portfolio. ORIC proved to be the most loss making stock for the portfolio. SPY was the most profitable stock for Euclidean Capital LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.75 | 1,307,860 | 5,937,680 | unchanged | 0.00 | ||
| AMPS | ishares tr | 17.00 | 2,425,140 | 135,275,000 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 1.14 | 1,573,760 | 9,049,130 | unchanged | 0.00 | ||
| GLD | spdr gold tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ME | 23andme holding co | 0.50 | 10,243,100 | 4,007,110 | unchanged | 0.00 | ||
| NGM | ngm biopharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ORIC | oric pharmaceuticals inc | 0.88 | 989,410 | 6,995,130 | unchanged | 0.00 | ||
| PMVP | pmv pharmaceuticals inc | 0.54 | 2,627,640 | 4,256,780 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 0.25 | 657,899 | 2,006,590 | unchanged | 0.00 | ||
| SPY | spdr s&p 500 etf tr | 78.43 | 1,146,980 | 624,209,000 | added | 17.68 | ||
| SRZN | surrozen inc | 0.12 | 87,696 | 960,271 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.00 | 170,833 | 2,836 | unchanged | 0.00 | ||
| TNYA | tenaya therapeutics inc | 0.40 | 1,015,700 | 3,148,690 | unchanged | 0.00 | ||